Top Story

Anticoagulant, antiplatelet medications carry rare dermatologic surgery hemorrhage risks

December 19, 2014

Dermatologists and dermatologic surgeons should be aware of the bleeding risks of anticoagulant and antiplatelet drugs used for cardiovascular diseases, according to findings from a recent literature review.

The researchers conducted a PubMed search for the keywords “aspirin,” “warfarin,” “clopidogrel,” “dabigatran,” “rivaroxaban,” “apixaban, “prasugrel” and “ticagrelor” and selected review articles and publications that emphasized perioperative management of oral anticoagulant or antiplatelet medications. A second PubMed search was conducted for the words “hemorrhage,” “bleeding” and “thrombosis” in association with “dermatology,” “dermatologic surgery” and “cutaneous surgery.”

Lowering Factor XI levels effective in prevention of venous thrombosis Meeting News CoverageVideo

Lowering Factor XI levels effective in prevention of venous thrombosis

December 11, 2014
SAN FRANCISCO – A late-breaking abstract presented at the ASH Annual Meeting and Exposition identified a novel approach to reducing the risk of postoperative…
Harry Roger Büller, MD, PhD Meeting News CoveragePerspective

Reducing Factor XI may prevent postoperative thrombotic events

December 10, 2014
SAN FRANCISCO — Targeting Factor XI using a novel agent was associated with a significant reduction in venous thromboembolism risk among patients undergoing knee…
Meeting News CoveragePerspective

CATCH: Tinzaparin reduced recurrent VTE in patients with active cancer

December 9, 2014
SAN FRANCISCO — Tinzaparin was associated with a reduced risk for venous thromboembolism without an increase in major bleeding compared with warfarin in a cohort…
CME
New Advances, New Options: Evaluating the Changing Landscape of Hemophilia

New Advances, New Options: Evaluating the Changing Landscape of Hemophilia to Optimize Patient Outcomes

This activity is supported by an educational grant from Biogen Idec.

The bleeding abnormalities associated with hemophilia can have devastating consequences for patients. Recent advances…
More »
CME
Activity cover

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates

This activity is supported by an educational grant from Merck & Co., Inc.

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »
In the Journals

Anticoagulant, antiplatelet medications carry rare dermatologic surgery hemorrhage risks

December 19, 2014
Dermatologists and dermatologic surgeons should be aware of the bleeding risks of anticoagulant and antiplatelet drugs used for cardiovascular…
Lowering Factor XI levels effective in prevention of venous thrombosis Meeting News CoverageVideo

Lowering Factor XI levels effective in prevention of venous thrombosis

December 11, 2014
SAN FRANCISCO – A late-breaking abstract presented at the ASH Annual Meeting and Exposition identified a novel approach to reducing the risk of…
Harry Roger Büller, MD, PhD Meeting News CoveragePerspective

Reducing Factor XI may prevent postoperative thrombotic events

December 10, 2014
SAN FRANCISCO — Targeting Factor XI using a novel agent was associated with a significant reduction in venous thromboembolism risk among…
Meeting News CoveragePerspective

CATCH: Tinzaparin reduced recurrent VTE in patients with active cancer

December 9, 2014
SAN FRANCISCO — Tinzaparin was associated with a reduced risk for venous thromboembolism without an increase in major bleeding compared with…
Untreated emboli may increase risk for recurrent venous thromboembolism Meeting News CoveragePerspective

Untreated emboli may increase risk for recurrent venous thromboembolism

December 9, 2014
SAN FRANCISCO — Untreated venous thromboembolism in cancer patients was associated with increased bleeding complications, according to results…
Sotatercept alleviated anemia burden in low-risk myelodysplastic syndrome Meeting News Coverage

Sotatercept alleviated anemia burden in low-risk myelodysplastic syndrome

December 8, 2014
SAN FRANCISCO — Treatment with sotatercept was associated with erythroid hematologic improvement and a reduction in red blood cell transfusion…
Meeting News CoveragePerspective

Luspatercept increased hemoglobin, decreased transfusion requirement in beta-thalassemia

December 8, 2014
SAN FRANCISCO – The recombinant fusion protein luspatercept increased hemoglobin levels in patients with nontransfusion-dependent…
Majority of newborns with sickle cell disease survived to adulthood Meeting News Coverage

Majority of newborns with sickle cell disease survived to adulthood

December 8, 2014
SAN FRANCISCO — Approximately 91% of newborns with sickle cell disease survived to age 25 years, although the mortality rate accelerated…
Yutaka Niihara, MD Meeting News Coverage

L-glutamine reduced painful crises, hospitalizations in sickle cell disease

December 7, 2014
SAN FRANCISCO — Patients with sickle cell disease who receive prescription-grade oral L-glutamine experienced fewer painful sickle cell crises…
Lisa Hicks

ASH releases new ‘Choosing Wisely’ recommendations

December 3, 2014
ASH today identified several treatments, tests and procedures for hematologic conditions that physicians and patients should question.The ABIM…
More Headlines »